Skip to main content

Annals of Nuclear Medicine

Ausgabe 12/2019

Inhalt (10 Artikel)

Open Access Invited Review Article

From the respective expert viewpoints of the ANM specialty editors

Masayuki Inubushi, Miho Shidahara, Yasuyuki Takahashi, Mikako Ogawa, Yasushi Kiyono

Original Article

Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma

Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Kyeong Min Kim, Dong-Yeop Shin, Hye Jin Kang, Sang Moo Lim

Original Article

PSMA SPECT/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels

Christian Schmidkonz, Theresa Ida Goetz, Torsten Kuwert, Philipp Ritt, Olaf Prante, Tobias Bäuerle, Peter Goebell, Michael Cordes

Original Article

Association between carotid 18F-NaF and 18F-FDG uptake on PET/CT with ischemic vascular brain disease on MRI in patients with carotid artery disease

Kengo Fujimoto, Takashi Norikane, Yuka Yamamoto, Yasukage Takami, Katsuya Mitamura, Masaki Okada, Tetsuhiro Hatakeyama, Masahiko Kawanishi, Yoshihiro Nishiyama

Original Article

Potential prognostic implications of myocardial thallium-201 and iodine-123-beta-methylpentadecanoic acid dual scintigraphy in patients with Anderson–Fabry disease

Tomoaki Haga, Takahiro Okumura, Satoshi Isobe, Fuji Somura, Naoaki Kano, Tasuku Kuwayama, Tsuyoshi Yokoi, Hiroaki Hiraiwa, Toru Kondo, Akinori Sawamura, Ryota Morimoto, Hiroshi Yamamoto, Kazuya Tsuboi, Toyoaki Murohara

Original Article

Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer

Sara Pellegrino, Rosa Fonti, Emanuela Mazziotti, Luisa Piccin, Eleonora Mozzillo, Vincenzo Damiano, Elide Matano, Sabino De Placido, Silvana Del Vecchio

Short Communication

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients

Nicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, Nieves Martinez Chanza, Thierry Gil, Alexandre Peltier, Patrick Flamen